中东和非洲肉毒毒素市场将从 2022 年到 2031 年以 12.8% 的复合年增长率增长,达到 4.5355 亿美元

Publication Month : Dec 2023

  • Report Code : TIPRE00033005
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Inquire Before Buy

PRICING

$3550

$3195

中东和非洲肉毒毒素市场规模预计将从 2022 年的 1.7257 亿美元增至 2030 年的 4.5355 亿美元。预计 2022 年至 2030 年该市场的复合年增长率将达到 12.8%。

市场见解和分析师观点:

肉毒杆菌注射可阻断来自导致肌肉收缩的神经的化学信号。注射可以放松导致皱眉纹和其他面部皱纹的面部肌肉。肉毒杆菌是一种由肉毒杆菌产生的毒素开发的药物。肉毒杆菌毒素有多种类型,A 型和 B 型通常用于医疗和美容目的。

肉毒杆菌毒素用于治疗各种医疗状况,包括慢性偏头痛、肌肉痉挛和某些神经系统疾病失调。它还因其美容应用而广为人知,特别是以肉毒杆菌注射的形式,以减少面部皱纹和细纹的出现。在医疗和美容环境中,肉毒杆菌毒素被直接注射到特定的肌肉中。这种毒素会阻断注射肌肉中的神经信号,导致暂时性肌肉麻痹。肉毒杆菌毒素的作用是暂时的,通常持续几个月。通常需要重复注射才能维持所需的结果。

虽然医疗专业人员以适当剂量注射肉毒杆菌毒素通常被认为是安全的,但可能存在副作用和风险。常见的副作用包括暂时性瘀伤和肌肉无力。对于考虑肉毒杆菌毒素治疗的个人来说,咨询合格的医疗保健专业人员以评估适合性并讨论潜在的风险和益处至关重要。此外,有关肉毒杆菌毒素使用的法规可能因国家和地区而异。

由于多种因素,例如中东可支配收入的增加、人们对肉毒杆菌毒素益处的认识不断提高,神经系统疾病的患病率不断上升,以及肉毒杆菌毒素在治疗各种疾病中的应用不断增加。市场预计还将受益于新型肉毒毒素产品和应用的开发。然而,与肉毒杆菌毒素相关的副作用阻碍了中东和非洲肉毒杆菌毒素市场的增长。

增长动力和挑战:

对肉毒杆菌毒素益处的认识不断提高推动中东和非洲肉毒杆菌毒素毒素市场增长

由于可支配收入的增加,中东地区的人们愿意在美容手术上花钱。肉毒杆菌毒素注射是一种流行的美容手术,因为它们相对快速、简单且有效。中东地区的人们越来越意识到肉毒毒素注射对于美容和治疗目的的好处。肉毒杆菌毒素注射可用于治疗皱纹、眉间纹和鱼尾纹。肉毒杆菌毒素是一种有效且安全的治疗各种神经系统疾病的方法,包括痉挛、肌张力障碍和偏头痛。中东神经系统疾病患病率的上升推动了对肉毒杆菌毒素注射的需求。肉毒杆菌毒素注射越来越多地用于治疗多汗症或出汗过多。多汗症可能是一种使人衰弱的疾病,会影响一个人的社交和职业生活。肉毒杆菌毒素注射可以有效缓解多汗症症状。微创手术越来越受欢迎,因为与传统外科手术相比,微创手术疼痛少、疤痕少、恢复时间短。肉毒杆菌毒素注射是微创手术,可以在医生办公室进行。由于上述因素,中东和非洲肉毒毒素市场预计在未来几年将增长。

战略见解

细分和范围:

“中东和非洲肉毒毒素市场”根据产品、应用、最终用户和国家进行细分。

根据产品,中东和非洲肉毒毒素市场分为 Botox、Dysport、Xeomin 等。 Botox 细分市场在 2022 年占据最大的市场份额,预计在预测期内将保持其主导地位。根据应用,市场分为医疗和美容。到 2022 年,医疗领域将占据更大的市场份额。然而,预计美容领域在预测期内将出现显着的复合年增长率。肉毒杆菌毒素市场按最终用户划分为医院和诊所、专科和皮肤科诊所等。专科和皮肤科诊所细分市场在 2022 年占据最大市场份额,预计在预测期内复合年增长率最高。

细分市场分析:

医疗细分市场领先2022 年中东和非洲肉毒毒素市场预计将在预测期内保持主导地位。肉毒杆菌毒素广泛用于治疗慢性偏头痛、成人痉挛、儿童痉挛等疾病。对于偏头痛,肉毒杆菌毒素 A 是一种注射到肌肉中的处方药物,具有预防慢性偏头痛成人头痛等临床效果。

肉毒杆菌毒素是美容领域最通用的制剂之一。它已被用于多种应用,例如治疗眉间和前额皱纹、眉毛重新定位和眶周皱纹。

区域分析:

基于国家、中东和非洲肉毒杆菌毒素市场分为沙特阿拉伯、阿联酋、南非、黎巴嫩、阿曼、约旦、卡塔尔、科威特、巴林以及中东和非洲其他地区。沙特阿拉伯拥有最大的市场份额,其次是阿联酋。

沙特阿拉伯是中东和非洲人口和经济最大的市场之一。近年来,整容手术的数量有所增加,无论是手术还是非手术。根据国际美容整形外科医生协会的一项研究,沙特阿拉伯在全球整容手术率最高的 25 个国家中排名第 22 位。中年女性对肉毒杆菌毒素、真皮填充剂、激光和化学换肤等侵入性较小的手术的接受程度有所提高,以获得自然的外观,而无需长时间的停工。

此外,预计用于治疗眉间纹的产品将获得越来越多的批准对中东和非洲肉毒毒素市场产生积极影响。 2022年10月,大熊制药宣布其肉毒毒素(BTX)产品Nabota已获得沙特阿拉伯和乌克兰政府的产品批准。

因此,上述因素推动了中东的增长和沙特阿拉伯的非洲肉毒毒素市场。

竞争格局和主要公司:

有机和无机增长战略是中东和非洲肉毒毒素市场发展的特点。许多公司都专注于有机增长战略,例如启动、扩张、增强和搬迁。市场上出现的无机增长策略包括并购、伙伴关系和合作。这些活动为中东和非洲肉毒毒素市场参与者的业务和客户群扩张铺平了道路。

2022 年 2 月,Merz Therapeutics 宣布将扩大与 Vensica Therapeutics 的战略合作伙伴关系,作为Merz Group 向这家以色列初创企业投资高达 300 万美元。这项投资是在 2021 年签署的战略许可和合作协议之后进行的,该协议将 Merz 的肉毒杆菌神经毒素 A (XEOMIN) 用于 Vensica 的创新超声辅助输送导管。因此,Merz 正在执行合同约定的选择权,参与 Vensica 的 C 轮融资并对这家初创公司进行进一步投资。 2021 年 8 月,Merz Therapeutics 与以色列泌尿科初创公司 Vensica Therapeutics Ltd. 宣布,他们已签订战略许可和合作协议,利用 Vensica 的创新超声波将肉毒杆菌神经毒素 A (XEOMIN) 输送到膀胱壁-辅助分娩导管。由此,Merz Therapeutics 成为泌尿科适应症任何无针应用的独家毒素供应商,例如膀胱过度活动症、神经源性膀胱、间质性膀胱炎和其他泌尿科适应症。公司简介

Merz Pharma GmbH & Co KGaAAbbVie IncRevance Therapeutics IncIpsen SAmedytox IncEvolus IncHugel Inc兰州生物制品研究所GuficMetabiologics, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment by application is dominating the Middle East and Africa Botulinum Toxins market?

Answer: - The Middle East and Africa botulinum toxin market by application is segmented into medical and aesthetic. The medical segment held the largest share of the Middle East and Africa Botulinum Toxin market, and it is anticipated to register the highest CAGR.

What are the driving factors for the Middle East and Africa Botulinum toxins market across the world?

Answer: The factors that are driving the growth of market are growth are increasing disposable incomes in the Middle East, increasing awareness of the benefits of botulinum toxin, growing prevalence of neurological disorders, and increasing applications of botulinum toxin in the treatment of various diseases.

Who are the major players in market the Middle East and Africa Botulinum Toxins market?

Answer: - The botulinum toxins market majorly consists of the players such as Merz Pharma GmbH & Co KGaA, AbbVie Inc, Revance Therapeutics Inc, Ipsen SA, Medytox Inc, Evolus Inc, Hugel Inc, Lanzhou Institute of Biological Products Co Ltd, Gufic, and Metabiologics, Inc.

Which segment by product is dominating the Middle East and Africa Botulinum Toxins market?

Answer: - The Middle East and Africa botulinum toxin market by product is segmented into Botox, Dysport, Xemoin, and others. The Botox segment held the largest share of the Middle East and Africa Botulinum Toxin market, and it is anticipated to register the highest CAGR.

What is the Botulinum toxins?

Answer: Botox injections block chemical signals from nerves that cause muscle contraction. The Botox injections relax the facial muscles that cause frown lines and other facial wrinkles. Botox is a drug developed from a toxin produced by the bacterium Clostridium botulinum. There are various types of botulinum toxin, with types A and B being commonly used for medical and cosmetic purposes.

The List of Companies - Middle East and Africa Botulinum Toxin Market

  1. Merz Pharma GmbH & Co. KGaA
  2. AbbVie Inc.
  3. Revance Therapeutics Inc.
  4. Ipsen SA
  5. List Biological Labs Inc.
  6. Medytox Inc.
  7. Evolus Inc.
  8. Hugel Inc.
  9. Lanzhou Institute of Biological Products Co. Ltd.
  10. Supernus Pharmaceuticals
  11. Gufic

 

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports